Condition
Pneumococcal Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Pneumococcal Disease clinical trials that are recruiting, at sites in 16 countries (most in United States (5), Australia (2), Finland (2)). By phase: Phase 3 (5), Phase 4 (3), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 16Countries
Newest Pneumococcal Disease clinical trials
All recruiting trials (9)
-
Safety and immune response of three PG4 vaccine lots vs 20vPnC in adults
This study tests three different lots of a new pneumococcal vaccine and the standard 20vPnC vaccine in adults to see if they are similarly safe and provoke a similar immune response.
-
New pneumococcal vaccine safety and immune response in children and teens
This study tests whether a new pneumococcal vaccine is as safe and as effective as Prevnar 20 in children and adolescents who have previously received PCV.
-
New pneumococcal vaccine in infants shows safety and how it stacks up against Prevnar 20
A new pneumococcal vaccine is being tested in healthy infants to see if it is as safe as Prevnar 20 and whether it triggers a similar or better immune response.
-
New pneumococcal vaccine for healthy infants
A new pneumococcal vaccine is being tested in about 2-month-old healthy babies to see if it is as safe as Prevnar 20 and whether it may offer broader protection against germs that cause pneumonia, meningitis, and ear infections.
-
Serum collection after Gamma-PN vaccination to support assay development
This project will collect blood samples from people who receive the Gamma-PN vaccine to help develop lab tests for pneumococcal disease.
-
How pneumococcal conjugate vaccines may produce antibodies that protect against serogroup 33.
This will try two different pneumococcal conjugate vaccines in healthy adults to see which one makes antibodies that can kill serogroup 33 bacteria.
-
Pneumococcal Vaccine Test for severely malnourished kids in hospital
This study tests whether giving Pneumosil to children aged 6–59 months with severe acute malnutrition in hospital elicits a better immune response than a Typhoid vaccine, with follow-up visits over six months.
-
Assessing the effectiveness of a new pneumococcal vaccine in healthy adults
This study is testing a new pneumococcal vaccine to see if it helps healthy adults aged 18-50 fight off an infection caused by a specific bacteria.
-
Evaluating a Pneumococcal Vaccine in Healthy Individuals
This study is testing a new pneumococcal vaccine in healthy people aged 2 and older to see how well it works and if it's safe.
Related topics
Quick answers
How many Pneumococcal Disease clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 16 countries. The most sites are in United States (5 trials), Australia (2 trials), Finland (2 trials), Poland (2 trials), Puerto Rico (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 5, Phase 4: 3, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.